A Review on Patient Perception for Branded and Generic Medicines

Abstract

The use of branded or established medicines has been a warm topic in modern-day years on a global scale. The usage of common medicines in vicinity of branded ones is likewise strictly advocated with the useful resource of the governments of some international locations. The active chemical materials in a regular medicinal drug are similar to those in a branded remedy, and everywhere proven to have similar healing efficacy. Improved use of time-honoured medications would possibly decrease costs without compromising the quality of the drug treatments because branded medicinal capsules are slightly more luxurious than commonplace ones. The safety, and effectiveness of often taking place medicinal tablets are same to the ones in their unique brand opposite numbers. In many nations, preferred medicinal capsules are endorsed to restrict pharmaceutical spending that allows you to maintain the fitness care system thinking about they provide the equal healing results at a significantly lower fee. Conventional medicines are typical appreciably greater quick than branded drug treatments. because of the period of time it takes for branded medications to be permitted, and the charges associated with their development, branded medicinal drugs in the end up steeply priced available on the market, whereas regular medicinal drugs are less steeply priced. Not unusual medicines are those whose proper patent has expired, making it possible for organizations apart from the authentic inventor to supply and marketplace them. After the actual organisation's patent expires, one-of-a-kind agencies can manufacture and marketplace widely wide-spread versions of name-emblem medications. In accordance to analyse, there are nevertheless issues over the first-class, safety, and effectiveness of famous medicines, even though many human beings see them as an inexpensive opportunity. Patients are much more likely to believe and take shipping of generics in rich countries with extra stringent regulations and much less complicated get entry to facts. Physicians and pharmacists have a large effect on these picks. After they assertively advise commonplace medicinal pills and make clear that they may be further effective as name-brand ones. To assist people, recognize and agree with in generics, its miles important to pay attention on affected person schooling, transparent verbal exchange, and requirements.

Keywords

Introduction

A generic medicine is a pharmaceutical drug that contains the same active ingredients as a branded drug product in terms of safety, dosage, strength, route of administration, quality, performance characteristics, and therapeutic use [1]. According to the World Health Organization, the term “generic drug,” or “generic medicine” is defined as medicine whose patent has expired and which is now produced by producers other than the original innovator (patent-holding) company [2]. The term “branded drug” or “brand name medicine” is defined as a name given to a pharmaceutical product by the manufacturer/producer [3].

Although generic medicines are much cheaper than brand-name medicines and also contain the same active substances as brand-name medicines, it is not well adapted in the Indian scenario [4]. In view of this, The Medical Council of India amended in 2018 to the code of conduct for doctors, recommending that every physician should prescribe drugs with generic names [5]. The use of generic medicines, compared to their branded counterparts, has the potential to substantially reduce out-of-pocket expenditure on drugs for patients with chronic diseases [6]. To address this issue, the Department of Pharmaceuticals, the Ministry of Chemicals and Fertilizers, and the Government of India launched the scheme “Pradhan Mantri Bhartiya Janaushadhi Pariyojana” in the year 2008 (Medicine for people) to provide cheap generic medicines to the ill-patients [7]. Under this scheme, dedicated outlets called “Janaushadhi Kendras” are opened to provide generic medicines at reasonable and affordable prices.

Generic substitution of brand prescriptions is an accepted practice in many parts of the world, and this is often done for economic reasons [8]. In India, however, generic substitution is not a universally accepted practice. This results from various factors including no availability of generic formulations, distrust of generic medicines by practitioners often due to perceived inferior quality and counterfeiting of drugs. [8][9]

1. BACKGROUND OF GENERIC AND BRANDED MEDICINES
   1. GENERIC MEDICINES

Generic medicines are those where the original patent has expired and which may now be produced by manufacturers other than the original innovator (patent-holding) company. The term “generic drug “or “generic medicine” can have varying definitions in different markets, however the term is commonly understood, as defined by the World Health Organisation (WHO), to mean a pharmaceutical product which:

1. Usually intended to be interchangeable with an innovator product,
2. manufactured without a licence from the innovator company, and
3. marketed after the expiry date of the patent or other exclusive rights. [10]

2.2 BRANDED MEDICINES

Branded medicines, also known as innovator or originator drugs, are pharmaceutical products marketed under a proprietary trade name by the company that first develops them. These drugs undergo extensive research, clinical trials, and regulatory approval before being introduced into the market. [11] They are typically protected by patents, granting exclusive marketing rights for a specific period. A generic drug is usually manufactured without a license from the original innovator. A generic drug product hits the market-place after the expiry of all patent and marketing exclusivity rights of an innovator’s product. Bioequivalence is defined as “the absence of a significant difference in the rate and extent to which the active ingredient or active moiety in pharmaceutical equivalents or pharmaceutical alternatives becomes available at the site of drug action when administered at the same molar dose under similar conditions in an appropriately designed study”. [12]

2. MISCONCEPTIONS AND MYTHS OF BRANDED AND GENERIC MEDICINES

Medicines are broadly categorized into branded (innovator) medicines and generic medicines. While branded medicines are marketed under proprietary names by pharmaceutical companies, generic medicines are equivalent versions introduced after patent expiry. [13] Despite regulatory assurances of equivalence, numerous misconceptions persist among patients, healthcare professionals, and even pharmacists regarding the quality, safety, and efficacy of generic medicines.In addition, there is empirical evidence demonstrating differential use of generics in younger patients, patients cared for by specialists, and patients who live in poorer neighbourhoods—all of whom are less likely than others to receive generic drugs. Patients’ and providers’ perceptions about the efficacy, safety, or value of generic drugs may be responsible for these inconsistencies. These misconceptions significantly influence prescribing patterns, patient adherence, and healthcare costs. [10]

1. 1. Generic medicines are less effective than branded medicines

One of the most common beliefs is that generic medicines are inferior in effectiveness compared to branded drugs. Many patients assume that lower cost implies lower therapeutic value.

Reality: Generics must demonstrate bioequivalence, meaning they work in the same way and provide the same therapeutic effect as branded drugs. [14]

1. 2. Generic medicines are of poor-qualityCommon Misconceptions about Branded and Generic Medicines

Another widespread misconception is that generic medicines are manufactured with lower quality standards. Patients often equate lower price with inferior quality.

Reality: Generic drugs must comply with strict regulatory standards for manufacturing, quality control, and safety. Despite this, studies reveal that a significant proportion of patients and even pharmacists believe generics are of inferior quality. This misconception is often driven by lack of awareness and inadequate patient education. [15]

1. 3. Generic medicines are less safe and cause more side effects

Some healthcare providers and patients believe that generic medicines are associated with more adverse effects compared to branded drugs.

Reality: Generic medicines are required to meet the same safety and efficacy standards as branded medicines before approval. Nevertheless, studies show that doctors and patients often perceive generics as less safe, highlighting a gap between scientific evidence and public perception. [14]

3.4 Branded medicines are always superior

There is a strong belief that branded medicines are inherently better due to their higher price and well-known brand names.

Reality: This perception is largely influenced by pharmaceutical marketing and brand recognition rather than scientific evidence. Studies demonstrate that patients often believe branded drugs are more potent and effective, even when no clinical difference exists.Such beliefs contribute to unnecessary healthcare expenditure and limit the use of cost-effective alternatives. [16]

3. FACTORS CONTRIBUTING TO MISCONCEPTIONS

4.1 Lack of Awareness and Education

Limited knowledge about drug regulation and bioequivalence contributes to misunderstanding among both patients and healthcare professionals.

4.2. Influence of Pharmaceutical Marketing

Aggressive marketing strategies by pharmaceutical companies promote branded medicines, reinforcing perceptions of superiority.

4.3 Socioeconomic and Cultural Factors   

Studies show that individuals with lower education levels are more likely to mistrust generic medicines.

4.4 Physician Influence

Patients often rely on physicians’ opinions. If physicians express doubts about generics, patients are less likely to accept them.

4. ROLE OF HEALTHCARE PROFESSIONALS IN PERCEPTION OF BRANDED AND GENERIC MEDICINES

5.1 Role of Doctor in Perception about Branded and generic Medicines are

Understanding of doctor's perceptions about generic medicines compare to brand medicine may help to eradicate possible barriers related to the usage of generic drug. The perception of doctors regarding the safety index of generic medicines can vary depending on various factors such as their experience, knowledge, and exposure to different brands and formulations [7] generic medicine use has become more widespread, there is evidence that many doctors and pharmacists hold negative views of generics and resist prescribing generic medicines. [17][7] Many doctors oppose brand substitution, believing generic medicines to be inferior to their branded counterparts. [17] In the UK, there was strong opposition when plans were proposed to introduce generic substitution into UK primary care, as well as controversy about using generic antiepileptic drugsand generic pregabalin for pain control. [18]

A number of surveys have also shown sizable proportions of patients reporting negative views about generics, believing them to be less effective, of lower quality and unsuitable for treatment of major illnesses, as compared to their branded equivalents. Such negative views of generic medicines are important because they are likely to be associated with poorer health outcomes due to an association with higher side effect reporting and lower adherence.

5.2 Role of pharmacist in perception toward branded and generic medicines

In developed countries' health care system, the role of the pharmacist has progressed from a merely dispenser to caregiver, counsellor, and decision-maker. [19] Pharmacists are considered as the direct and last line of contact with the patients. Also, as health-care professionals are expected to give advice patients regarding dosages, expected side effects and adverse effects, and drug-drug interactions and to take part in the multidisciplinary team as a practicing pharmacist. Therefore, evaluation of community pharmacists’ views and attitudes regarding the use of generic medicines and substitution is vital. To the best of our knowledge, no studies have been conducted to evaluate perception, knowledge and attitude of community pharmacists towards generic medicine dispensing in Kuwait. [20]

5. PRADHAN MANTRI BHARTIYA JANAUSHADHI PARIYOJANA [PMBJAP], INDIA

PMBJAP turned into launched in 2008 and re branded in 2016 under the Ministry of chemicals and Fertilizers, implemented via the Bureau of Pharma PSUs of India (BPPI). The purpose of the scheme is to make essential drug treatments handy and low-priced with the aid of promoting familiar substitutes of branded pills via committed shops known as “Pradhan Mantri Bharatiya Janaushadhi Kendras (PMBJKs)” or “Jan Ausadhi Kendras”. [21]

Even though India is the sector's pinnacle exporter of everyday medications, many of Indian patients nonetheless cannot have enough money them. India has one of the maximum out-of-pocket prices inside the world, accounting for 52% of fitness costs in 2019–2020, in step with the country wide fitness debts Estimates. In keeping with a go-sectional look at that checked out several country wide Statistical workplace (NSO) surveys, out-of-pocket clinical charges drove 55 million Indians into poverty among 1994 and 2014. [22],[23] The government of India launched Pradhan Mantri Bharatiya Janaushadhi Pariyojana, additionally referred to as Jan Ausadhi Yojna, to lessen the financial burden due to high-priced branded medicines. The intention of this software is to provide excellent conventional drugs at low fee to masses via unique stores referred to as Jan Ausadhi Kendras, as towards the highly priced branded tablets usually available at regular pharmacies. [24]

6. OBJECTIVES

1. To pick out the elements which influencing patient notion, which includes price, physician’s recommendation, previous revel in, severity of illness, and statistics from media or pharmacist.

2.To suggest sensible measures which include counselling, training, policy enter to improve affected person information and attractiveness of widespread drug treatments.

3. To look at that how charge of medicines affects affected person choice for branded and general medicines. [25], [26]

7. FACTOR INFLUENCING PATIENT DECISION-MAKING IN HEALTHCARE

Patient decision-making in healthcare is a complex, multifactorial process influenced by clinical, social, economic, and interpersonal determinants. In modern healthcare systems, patients are no longer passive recipients of care but active participants in treatment decisions. The concept of shared decision-making (SDM) emphasizes collaboration between patients and healthcare professionals, integrating clinical evidence with patient preferences and values

Among the many determinants, three major influencing domains are particularly significant: physician recommendations, pharmacist substitution practices, and socioeconomic and educational factors. These factors interact dynamically, shaping patient perceptions, treatment choices, adherence, and ultimately health outcomes. [27]

CONCLUSION

In summary, branded and generic medications differ mostly in price, name, and packaging, but they are therapeutically equal in terms of safety, quality, and efficacy. Due to misconceptions, ignorance, and pressure from medical professionals and the media, patients continue to prefer branded medications despite generic medications' shown efficacy and affordability. These perceptions are also greatly influenced by socioeconomic characteristics including education, money, and place of living. Enhancing patient education, fortifying healthcare regulations, and promoting generic prescriptions can lower healthcare costs, increase access to necessary therapies, and increase adoption of generic medications.

REFERENCES

1. M. Alam, “Patients ’ Perception Towards Branded and Generic Medicines in an Emerging Economy?: A Scale Development and Validation Study,” 2019, doi: 10.1177/0972150919846812.
2. P. Zhang, Q. Zhao, Y. Li, X. Niu, Y. Zhuang, and J. Liu, “Collaborative WiFi Fingerprinting Using Sensor-Based Navigation on Smartphones,” pp. 17534–17557, 2015, doi: 10.3390/s150717534.
3. A. Hinda, Y. Sebbahi, M. Hassaine, and Y. Tadlaoui, “Perception of Healthcare Professionals Regarding Generic Drugs?: Impact on their Prescription in Hospital Settings,” vol. 10, no. 5, pp. 3690–3695, 2025.
4. A. Chattoraj and M. Pareek, “International Journal of Life science and Pharma Research Prospects and Challenges of Generic Medicines Adoption in India?: Consumer and Physician Perspectives,” vol. 12, no. 5, pp. 51–60, 2022, doi: 10.22376/ijpbs/lpr.2022.12.5.P51-60.
5. N. B. Wakle and M. Wavhale, “Pharmaceutical Sales and Marketing,” vol. 12, no. 6, pp. 6673–6680, 2025.
6. R. K. Dehury, I. Ahmad, M. R. Behera, J. Samal, and V. Manchana, “Assessment of out ? of ? pocket ( OOP ) expenditures on essential medicines for acute and chronic illness?: a comparative study across regional and socioeconomic groups in India,” BMC Public Health, 2025, doi: 10.1186/s12889-025-21312-7.
7. . Colgan, K. Faasse, L. R. Martin, M. H. Stephens, A. Grey, and K. J. Petrie, “Perceptions of generic medication in the general population , doctors and pharmacists?: a systematic review,” 2015, doi: 10.1136/bmjopen-2015-008915.
8. A. Affordable and E. Healthcare, “Pradhan Mantri Bhartiya Janaushadhi Pariyojana ( PMBJP ),” 2027.
9. M. Azmi, A. A. Alrasheedy, and A. Mclachlan, “The experiences of implementing generic medicine policy in eight countries?: A review and recommendations for a successful promotion of generic medicine use,” Saudi Pharm. J., vol. 22, no. 6, pp. 491–503, 2014, doi: 10.1016/j.jsps.2013.12.017.
10. W. H. O. Guideline, C. Pharmaceutical, and P. Policies, “Promoting the use of quality ? assured generic and biosimilar medicines WHO Guideline on Country Pharmaceutical Pricing Policies,” pp. 2–3.
11. J. Luo, A. Sarpatwari, and A. S. Kesselheim, “Regulatory Solutions to the Problem of High Generic Drug Costs Regulatory Solutions to the Problem of High Generic Drug Costs,” vol. 2, no. 4, pp. 2–4, 2015, doi: 10.1093/o.
12. P. T. Doi et al., “Vrije Universiteit Brussel A Modern Pain Neuroscience Approach in Patients Undergoing Surgery for Lumbar Radiculopathy A Clinical Perspective Publication date?: License?: Document Version?: Accepted author manuscript,” 2019, doi: 10.1093/ptj/pzz053.
13. R. Van Den Ham, L. Bero, and R. Laing, “THE WORLD MEDICINES SITUATION 2011 SELECTION OF,” 2011.
14. S. S. Dunne and C. P. Dunne, “What do people really think of generic medicines?? A systematic review and critical appraisal of literature on stakeholder perceptions of generic drugs,” 2015, doi: 10.1186/s12916-015-0415-3.
15. Dunne S, Shannon B, Dunne C, Cullen W. A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study. BMC PharmacolToxicol. 2013;14:1.
16. B. Luo, F. Yu, W. Ge, and X. Yang, “Can Generic Medications Be a Safe and Effective Alternative to Brand-Name Drugs for Cardiovascular Disease Treatment?? A Systematic Review and Meta-Analysis,” vol. 26, no. 3, 2025.
17. Bauer LA, Harris C, Wilensky AJ, Raisys VA, Levy RH (1982) Ethosuximide kinetics: possible interaction with valproic acid. Clin PharmacolTher 31(6):741–745
18. M. Atif, M. Azeem, and M. R. Sarwar, “Potential problems and recommendations regarding substitution of generic antiepileptic drugs?: a systematic review of literature,” Springerplus, 2016, doi: 10.1186/s40064-016-1824-2.
19. S. Panigrahy, “Journal of Drug Delivery and Therapeutics Knowledge and Perceptions of Generic Drugs?: A Cross Sectional Study,” vol. 12, pp. 53–57, 2022.
20. . Millard, A. B. Kadam, R. Mahajan, and M. Allyson, “Availability of brands of six essential medicines in 124 pharmacies in Maharashtra,” vol. 8, no. 1, pp. 1–12, 2018, doi: 10.7189/jogh.08.010402.
21. A. R. Shabaraya and R. Shetty, “A Review On The Janaushadhi Scheme?: Transforming Acquisition To Affordable Medicines In India,” vol. 1, no. 12, pp. 88–94, 2023, doi: 10.5281/zenodo.10259580.
22. S. Selvaraj, H. H. Farooqui, and A. Karan, “Quantifying the financial burden of households ’ out-of-pocket payments on medicines in India?: a repeated cross- sectional analysis of National Sample Survey data , 1994 – 2014,” pp. 1–10, 2018, doi: 10.1136/bmjopen-2017-018020.
23. Alrasheedy AA, Hassali MA, Stewart K, et al. Patient knowledge,perceptions, and acceptance of generic medicines: a comprehensivereview of the current literature. Patient Intell2014;6:1–29.
24. A. Mandloi, “Supply Chain Management for India ’ s Health Journal of Chemical Health Risks,” vol. 14, pp. 357–371, 2024.
25.  Fraeyman, “Consumer Choice Between Common Generic and Brand Medicines in a Country with a Small Generic Market,” vol. 21, no. 4, 2015.
26. G. Elwyn et al., “Shared Decision Making?: A Model for Clinical Practice,” pp. 1361–1367, doi: 10.1007/s11606-012-2077-6.